We are live on ! Find out more

37 hedge funds and large institutions have $2.86M invested in BioVie in 2026 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more capital inflows, than outflows

Capital inflows: $1.11M | Capital outflows: $409K

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

5.85% more ownership

Funds ownership: 13.67% → 19.52% (+5.9%)

6% more funds holding

Funds holding: 35 → 37 (+2)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

Holders
37
Holders Change
+2
Holders Change %
+5.71%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
10
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BIVI Hedge Fund Activity: Q2 2026 in Review

37 of the 8,401 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q2 2026, worth a combined $2.86M — up 98% from $1.44M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new BIVI positions and 3 closed out — a net gain of 2 holders — while 9 added to existing stakes and 10 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $833K. The largest seller was Diametric Capital, cutting an estimated $178K.

  • 37 institutional investors held BioVie (BIVI) as of Q2 2026, up from 35 in Q1 2026.
  • Funds reported $2.86M of BioVie stock for Q2 2026, up 98% quarter-over-quarter.
  • 5 funds opened new BioVie positions in Q2 2026 and 3 closed out, a net change of +2 holders.
  • The largest BioVie buyer in Q2 2026 was Morgan Stanley, an estimated $833K added.
  • The largest BioVie seller in Q2 2026 was Diametric Capital, an estimated $178K sold.

Based on aggregated 13F filings for Q2 2026.